🚨 New publication!
We reviewed research on ADHD in kids with NF1, focusing on biological, psychological & social factors.
👉 Key takeaway: ADHD in NF1 is shaped by more than just biology—family, school & social supports matter too.
#ADHD#nfnetwork
https://t.co/BSFjdoyLt9
🚨 New publication!
We reviewed research on ADHD in kids with NF1, focusing on biological, psychological & social factors.
👉 Key takeaway: ADHD in NF1 is shaped by more than just biology—family, school & social supports matter too.
#ADHD#nfnetwork
https://t.co/BSFjdoyLt9
📣 News from @FSUDEaRLab’s ongoing research on neurofibromatosis type 1 (NF1): Individuals with NF1 show significantly reduced visuospatial and visuomotor abilities compared to those without the condition. 🧠
Learn More: https://t.co/xVDpwBsUCi
The DEaR Lab team shared seven research projects at the 2025 Neurofibromatosis (NF) Conference in D.C., including one platform talk and six posters on ADHD, cognitive function, academic skills, and mental health in individuals with NF1. 🧠📊
I’m incredibly proud of our amazing undergraduate students, Myintmo Tun and Sia Kakkar, for presenting our DEaR Lab projects at the FSU Undergraduate Research Symposium! 🎉#fsu#fsubssm#fsuresearch
🚨 New Meta-Analysis Alert!
Our review of 70 studies on ADHD symptoms in 3,653 children with NF1 underscores the critical need for early intervention and tailored support.
📖 Read more: https://t.co/ymiYa9IvGf
#ADHD#NF1#ChildHealth#EarlyIntervention#CTF#NFnetwork#JAACAP
✨ A recent research project by @YangHou3 and her lab dives deep into the psychosocial challenges faced by individuals with neurofibromatosis type 1 (NF1). ✨
The team found that those with NF1 experience higher levels of depression, anxiety, somatic symptoms, and aggression compared to those without NF1. 📊🔍
This research highlights the urgent need for early identification and intervention to improve quality of life for those affected.
Learn More: https://t.co/czSH1Sp9sS
The Development, Equity, and Resilience (DEaR) Lab in Florida State University is conducting a study on cognitive patterns and predictors in middle-aged and older adults with Neurofibromatosis Type 1 (NF1). Read about this study and others here: https://t.co/a9iuaJIC9e
🧠 Join us for the NF Knowledge Series webinar on NF1 Cognitive Research this Thursday, Jan 23 at 3 PM ET! Led by Dr. Yang Hou from @floridastate, learn the latest research on cognitive health in adolescents and adults with NF1. 🔗 Register now: https://t.co/Mi80xqhyko
#EndNF
🧠📢 Upcoming Webinar: Diagnosed with Schwannomatosis! Join us Feb 20 at 2 PM ET as Dr. Carlos Romo (@HopkinsMedicine) discusses the latest in SWN diagnosis & management and hear from patient advocates. 🔗 Register: https://t.co/Mi80xqhyko
#EndNF
🎉@YangHou3 has been awarded the 2024 Outstanding Junior Faculty Researcher Award by @FSUCoM! 🎉
In just two years, Dr. Hou has made significant strides in neurofibromatosis type 1 (NF1) and developmental research, publishing 13 articles in top journals, including 4 as first author. 📚
With national and international accolades, like the Early Career Outstanding Paper Award from the APA, 🏆 Dr. Hou is a rising star in developmental psychology and NF1 research! 🌟
The #RareDisease community needs you!
To find out why organisations like yours should support #RAREfest24 - visit our website & download a sponsorship invitation booklet or drop our MD [email protected] a line.
https://t.co/xGUkhlXyHj
YOUR sponsorship = THEIR spotlight
🚨🚨The 4th Annual #NFYIF Call for Abstracts is officially OPEN!
Are you a Jr Faculty, Fellow, Post Doc, or PhD student conducting active research in #NF? Submit your work for a chance to go to Baltimore in Dec!
Deadline Sept 9: https://t.co/X91tuXcyyn
@ChildrensTumor#NFYIF24
Development, Equity, and Resilience (DEaR) Lab members, Drs. Yang Hou, Dan Liu, Xiaoli Zong, and Liyan Yu presented four studies on the neurobehavioral development of individuals with neurofibromatosis at the NF Global Conference.
@yanghou3@fsudearlab@ChildrensTumor#FSU #FSUCOM #BSSM #FSUHealth #NFCon24 #EndNF